Newton Biocapital
Newton Biocapital is a Belgium-based venture capital fund focused on financing biotech and life science projects in Europe (Belgium, Netherlands, Germany, France) and Japan. As lead investor, they support promising start-ups and neglected late-stage projects to mitigate risks and create value. The team consists of specialists with extensive management and investment experience who coach bio-entrepreneurs through project development stages.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Belgium
Augustine Therapeutics
Series A in 2025
Augustine Therapeutics N.V. is a biopharmaceutical company based in Gent, Belgium, focused on developing innovative therapies for patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular disorders. Founded in 2019, the company is engaged in two drug discovery programs aimed at identifying novel selective HDAC6 inhibitors. These compounds are designed to prevent nerve degeneration and facilitate the repair of peripheral myelin and axons. Through its research and development efforts, Augustine Therapeutics seeks to enhance the quality of life for patients affected by these debilitating conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.